Abstract:Pancreatic ductal adenocarcinoma (PDAC) is a treatment-refractory malignancy with a dismal prognosis. Cancer cell plasticity – the capacity to differentiate and adapt to cell-extrinsic pressure via non-genetic mechanisms – promotes PDAC progression and drives resistance to treatment. Thus, targeting plasticity is a promising therapeutic strategy yet plasticity drivers in PDAC remain poorly understood. Using genetically engineered mouse models driven by oncogenic KrasG12D and loss of p53 ("KPC" model), we profiled primary PDAC tumors using single-cell RNA sequencing and single cell ATAC sequencing. We identified a cancer cell differentiation state that co-expresses both epithelial and mesenchymal programs and has a distinct epigenetic landscape with accessible chromatin across gene sets that mark cancer cell states with divergent phenotypes, suggesting that this cell state is primed for cell state switching. Notably, this high-plasticity cell state (HPCS) signature aligns with a "basal" signature in human PDAC, which associates with poor prognosis and resistance to chemotherapy. To functionally interrogate the HPCS in PDAC progression, we developed a novel lineage-tracing and ablation system allowing (1) visualization of cells in a specific state; (2) timed introduction of a heritable mark allowing us to track cell state progeny; and (3) timed cell state killing via a suicide gene. Lineage-tracing experiments revealed that the HPCS has a robust capacity for differentiation into epithelial/"classical" and mesenchymal states, indicating that the HPCS is functionally plastic and acts as a source of fixed malignant states. Strikingly, targeted elimination of the HPCS over short time periods resulted in tumor collapse, underscoring a critical role in tumor maintenance. Taken together, our data indicates that PDAC harbors a striking dependency on the HPCS, which drives malignant cell state transitions, promotes intra-tumoral diversity, and is critical for tumor maintenance. Our results strongly encourage therapeutic approaches aimed at eradicating this critical subset of cancer cells to improve outcomes in PDAC. Citation Format: Anupriya Singhal, Hannah Styers, Yan Yan, Simon Joost, Kenneth Pitter, Olivera Grbovic-Huezo, Hulya Sahin, Olca Basturk, Tuomas Tammela. Functional dissection of the basal cell state in pancreatic cancer [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Pancreatic Cancer; 2023 Sep 27-30; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(2 Suppl) nr C105.

TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma

Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma

TP63 Links Chromatin Remodeling and Enhancer Reprogramming to Epidermal Differentiation and Squamous Cell Carcinoma Development

A mucus production programme promotes classical pancreatic ductal adenocarcinoma

Abstract IA13: Developmental and MAPK-responsive programs drive distinct malignant subtypes and dependencies in pancreatic cancer

Interaction Between MED12 and ΔNp63 Activates Basal Identity in Pancreatic Ductal Adenocarcinoma

Biological Characteristics of Pancreatic Ductal Adenocarcinoma: Initiation to Malignancy, Intracellular to Extracellular.

Abstract 3050: Evaluating the role of ∆Np63α in driving growth and metastasis of pancreatic ductal adenocarcinoma

Abstract C105: Functional dissection of the basal cell state in pancreatic cancer

Loss of p53 tumor suppression function drives invasion and genomic instability in models of murine pancreatic cancer

Abstract C069: A Conserved Reepithelialization Program Driven by FOSL1 Underlies Malignancy in Pancreatic Ductal Adenocarcinoma

Epigenetic regulation of p63 blocks squamous-to-neuroendocrine transdifferentiation in esophageal development and malignancy

The scRNA-sequencing landscape of pancreatic ductal adenocarcinoma revealed distinct cell populations associated with tumor initiation and progression

Protein kinase D1 drives pancreatic acinar cell reprogramming and progression to intraepithelial neoplasia

CTHRC1+ fibroblasts and SPP1+ macrophages synergistically contribute to pro-tumorigenic tumor microenvironment in pancreatic ductal adenocarcinoma

Abstract B052: Uncovering the lineage of chemosensory cells in the progression of pancreatic cancer

Transcriptional deconvolution reveals consistent functional subtypes of pancreatic cancer epithelium and stroma

Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression

Tuft cells transdifferentiate to neural-like progenitor cells in the progression of pancreatic cancer

ΔNP63 defines an exocrine-committed multipotent progenitor subset in the murine pancreas

Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming